Literature DB >> 28951297

Targeting activator protein 1 signaling pathway by bioactive natural agents: Possible therapeutic strategy for cancer prevention and intervention.

Devesh Tewari1, Seyed Fazel Nabavi2, Seyed Mohammad Nabavi3, Antoni Sureda4, Ammad Ahmad Farooqi5, Atanas G Atanasov6, Rosa Anna Vacca7, Gautam Sethi8, Anupam Bishayee9.   

Abstract

Activator protein 1 (AP-1) is a key transcription factor in the control of several cellular processes responsible for cell survival proliferation and differentiation. Dysfunctional AP-1 expression and activity are involved in several severe diseases, especially inflammatory disorders and cancer. Therefore, targeting AP-1 has recently emerged as an attractive therapeutic strategy for cancer prevention and therapy. This review summarizes our current understanding of AP-1 biology and function as well as explores and discusses several natural bioactive compounds modulating AP-1-associated signaling pathways for cancer prevention and intervention. Current limitations, challenges, and future directions of research are also critically discussed.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Activator protein 1; Apoptosis; Caffeic acid (PubChem CID: 689043); Cancer; Curcumin (PubChem CID: 969516); Inflammation; Isohamnetin (PubChem CID: 15817847); Kaempferide (PubChem CID: 5281666); Natural compounds; Quercetin (PubChem CID: 5280343); Resveratrol (PubChem CID: 445154); Viscolin (PubChem CID: 16079989)

Mesh:

Substances:

Year:  2017        PMID: 28951297     DOI: 10.1016/j.phrs.2017.09.014

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN: 1043-6618            Impact factor:   7.658


  54 in total

Review 1.  The vital role of ATP citrate lyase in chronic diseases.

Authors:  Amrita Devi Khwairakpam; Kishore Banik; Sosmitha Girisa; Bano Shabnam; Mehdi Shakibaei; Lu Fan; Frank Arfuso; Javadi Monisha; Hong Wang; Xinliang Mao; Gautam Sethi; Ajaikumar B Kunnumakkara
Journal:  J Mol Med (Berl)       Date:  2019-12-19       Impact factor: 4.599

Review 2.  Long non-coding RNAs are emerging targets of phytochemicals for cancer and other chronic diseases.

Authors:  Shruti Mishra; Sumit S Verma; Vipin Rai; Nikee Awasthee; Srinivas Chava; Kam Man Hui; Alan Prem Kumar; Kishore B Challagundla; Gautam Sethi; Subash C Gupta
Journal:  Cell Mol Life Sci       Date:  2019-03-16       Impact factor: 9.261

3.  Modulation of TLR/NF-κB/NLRP Signaling by Bioactive Phytocompounds: A Promising Strategy to Augment Cancer Chemotherapy and Immunotherapy.

Authors:  Sajad Fakhri; Seyed Zachariah Moradi; Akram Yarmohammadi; Fatemeh Narimani; Carly E Wallace; Anupam Bishayee
Journal:  Front Oncol       Date:  2022-03-01       Impact factor: 6.244

4.  Alantolactone exhibits antiproliferative and apoptosis-promoting properties in colon cancer model via activation of the MAPK-JNK/c-Jun signaling pathway.

Authors:  Yijing Ren; Cheng Lv; Jing Zhang; Beibei Zhang; Bei Yue; Xiaoping Luo; Zhilun Yu; Hao Wang; Junyu Ren; Zhengtao Wang; Wei Dou
Journal:  Mol Cell Biochem       Date:  2021-08-30       Impact factor: 3.396

Review 5.  Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action.

Authors:  Mitra Behroozaghdam; Maryam Dehghani; Amirhossein Zabolian; Davood Kamali; Salar Javanshir; Farzaneh Hasani Sadi; Mehrdad Hashemi; Teimour Tabari; Mohsen Rashidi; Sepideh Mirzaei; Atefeh Zarepour; Ali Zarrabi; Danielle De Greef; Anupam Bishayee
Journal:  Cell Mol Life Sci       Date:  2022-10-04       Impact factor: 9.207

6.  MALINC1 an Immune-Related Long Non-Coding RNA Associated with Early-Stage Breast Cancer Progression.

Authors:  María Laura Fabre; Romina Canzoneri; Agustina Gurruchaga; Jaeho Lee; Pradeep Tatineni; Hyunsuk Kil; Ezequiel Lacunza; C Marcelo Aldaz; Martín Carlos Abba
Journal:  Cancers (Basel)       Date:  2022-06-07       Impact factor: 6.575

Review 7.  From Simple Mouth Cavities to Complex Oral Mucosal Disorders-Curcuminoids as a Promising Therapeutic Approach.

Authors:  Sosmitha Girisa; Aviral Kumar; Varsha Rana; Dey Parama; Uzini Devi Daimary; Saman Warnakulasuriya; Alan Prem Kumar; Ajaikumar B Kunnumakkara
Journal:  ACS Pharmacol Transl Sci       Date:  2021-03-17

8.  Extracts from Pulsatilla patens target cancer-related signaling pathways in HeLa cells.

Authors:  Grażyna Łaska; Magdalena Maciejewska-Turska; Elwira Sieniawska; Łukasz Świątek; David S Pasco; Premalatha Balachandran
Journal:  Sci Rep       Date:  2021-05-20       Impact factor: 4.379

9.  SETBP1 accumulation induces P53 inhibition and genotoxic stress in neural progenitors underlying neurodegeneration in Schinzel-Giedion syndrome.

Authors:  Federica Banfi; Alicia Rubio; Mattia Zaghi; Luca Massimino; Giulia Fagnocchi; Edoardo Bellini; Mirko Luoni; Cinzia Cancellieri; Anna Bagliani; Chiara Di Resta; Camilla Maffezzini; Angelo Ianielli; Maurizio Ferrari; Rocco Piazza; Luca Mologni; Vania Broccoli; Alessandro Sessa
Journal:  Nat Commun       Date:  2021-06-30       Impact factor: 14.919

Review 10.  Targeting Mitochondrial Biogenesis with Polyphenol Compounds.

Authors:  Leila Chodari; Mutlu Dilsiz Aytemir; Parviz Vahedi; Mahdieh Alipour; Sepideh Zununi Vahed; Seyed Mahdi Hosseiniyan Khatibi; Elham Ahmadian; Mohammadreza Ardalan; Aziz Eftekhari
Journal:  Oxid Med Cell Longev       Date:  2021-07-12       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.